Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
With a market cap of 9.06B, Corcept Therapeutics(CORT) trades at $86.11. The stock has a price-to-earnings ratio of 96.73.
On 2025-12-06, Corcept Therapeutics(CORT) stock traded between a low of $83.60 and a high of $86.39. Shares are currently priced at $86.11, which is +3.0% above the low and -0.3% below the high.
The Corcept Therapeutics(CORT)'s current trading volume is 638.79K, compared to an average daily volume of 693.7K.
During the past year, Corcept Therapeutics(CORT) stock moved between $49.00 at its lowest and $117.33 at its peak.
During the past year, Corcept Therapeutics(CORT) stock moved between $49.00 at its lowest and $117.33 at its peak.
CORT News
Corcept Therapeutics (CORT) just posted third quarter earnings that topped profit expectations even as revenue missed forecasts, and the update landed alongside...
Earlier this week, Corcept Therapeutics revised its 2025 revenue guidance to US$800–US$850 million, reflecting capacity constraints with its former specialty ph...